CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02581410
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:49.483630+00:00
Published At: 2017-09-26T00:00:00+00:00
Record Updated At: 2018-08-28
Results Posted At: 2017-09-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Herpes Zoster"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-08-28"
protocolSection.identificationModule.nctId: "NCT02581410"
protocolSection.identificationModule.officialTitle: "Immunogenicity and Safety Study of GSK Biologicals\u0027 Herpes Zoster Vaccine GSK1437173A in Adults \u2265 65 Years of Age With and Without Zostavax\u00ae Vaccination at Least 5 Years Earlier"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-09-26"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.